DE602006011275D1 - Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat - Google Patents

Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat

Info

Publication number
DE602006011275D1
DE602006011275D1 DE602006011275T DE602006011275T DE602006011275D1 DE 602006011275 D1 DE602006011275 D1 DE 602006011275D1 DE 602006011275 T DE602006011275 T DE 602006011275T DE 602006011275 T DE602006011275 T DE 602006011275T DE 602006011275 D1 DE602006011275 D1 DE 602006011275D1
Authority
DE
Germany
Prior art keywords
epigallocatechingallate
compositions
protein hydrolyzate
protein
hydrolyzate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006011275T
Other languages
English (en)
Inventor
Swen Wolfram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of DE602006011275D1 publication Critical patent/DE602006011275D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
DE602006011275T 2005-02-03 2006-02-02 Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat Active DE602006011275D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100755 2005-02-03
PCT/EP2006/050623 WO2006082222A1 (en) 2005-02-03 2006-02-02 Compositions comprising epigallocatechin gallate and protein hydrolysate

Publications (1)

Publication Number Publication Date
DE602006011275D1 true DE602006011275D1 (de) 2010-02-04

Family

ID=36218397

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006011275T Active DE602006011275D1 (de) 2005-02-03 2006-02-02 Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat

Country Status (7)

Country Link
US (1) US8129337B2 (de)
EP (1) EP1843778B1 (de)
AT (1) ATE452646T1 (de)
DE (1) DE602006011275D1 (de)
ES (1) ES2337495T3 (de)
PL (1) PL1843778T3 (de)
WO (1) WO2006082222A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080262081A1 (en) * 2005-10-14 2008-10-23 Daniel Raederstorff Novel Use of Nutraceutical Compositions Comprising Resveratrol
WO2008027807A2 (en) * 2006-09-01 2008-03-06 University Of Southern California Control of diabetes and obesity
EP1969954A1 (de) * 2007-02-01 2008-09-17 DSMIP Assets B.V. (-)-Epigallocatechin-Gallat enthaltende Sosse
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
TWI736755B (zh) * 2017-04-03 2021-08-21 大江生醫股份有限公司 包含植物萃取物的組成物及其減少紫外線所致皮膚損傷之用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
GB9312369D0 (en) * 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
GB0206793D0 (en) * 2002-03-22 2002-05-01 Galactogen Products Ltd Alertness bar
AU2003236689A1 (en) * 2002-06-04 2003-12-19 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides

Also Published As

Publication number Publication date
EP1843778B1 (de) 2009-12-23
ES2337495T3 (es) 2010-04-26
WO2006082222A1 (en) 2006-08-10
PL1843778T3 (pl) 2010-06-30
US8129337B2 (en) 2012-03-06
US20080119389A1 (en) 2008-05-22
EP1843778A1 (de) 2007-10-17
ATE452646T1 (de) 2010-01-15

Similar Documents

Publication Publication Date Title
ATE452646T1 (de) Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat
EA200701528A1 (ru) Новые нутрицевтические композиции
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
DE602005010109D1 (de) 1,1a,5,5a-tetrahydro-3-thia-cyclopropaäaüpentaleneptor-agonisten
NO20043564L (no) Follistatindomene som inneholder proteiner
NO20052309D0 (no) Nutrasoytisk mangostanblanding.
ATE506362T1 (de) 1-aza-bicycloä3.3.1ünonane
DE60321307D1 (de) Wässrige harzzusammensetzung
DK1951697T3 (da) Substitueret 5-phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazin
ATE518848T1 (de) 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate
BR0300119B1 (pt) composiÇço aquosa.
BRPI0500536A (pt) Composição antimicrobiana
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
EA200800820A1 (ru) Композиция с замедленным высвобождением и ее применение
ATE504290T1 (de) Zusammensetzungen mit neramexan
ES1051506Y (es) Juguete de composicion.
DE50206079D1 (de) Transparentes wässriges beschichtungsmittel mit glasmehl
ITTO20020744A1 (it) Composizione.
ITPR20030089A1 (it) Valvola di omogeneizzazione.
ITTO20020745A1 (it) Composizione.
HN2002000177A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso.
ES1051818Y (es) Fuente.
ITRC20050012A1 (it) "palmira la bottiglia che attira".
DE50312860D1 (de) Schaltklappenanordnung
UY34598A (es) Antranilamidas insecticidas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition